- Home
- PCVX vs BRKR Comparison
PCVX vs BRKR Comparison
Compare PCVX & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- BRKR
- Stock Information
- Founded
- PCVX 2013
- BRKR 1960
- Country
- PCVX United States
- BRKR United States
- Employees
- PCVX N/A
- BRKR N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- PCVX Health Care
- BRKR Industrials
- Exchange
- PCVX Nasdaq
- BRKR Nasdaq
- Market Cap
- PCVX 4.4B
- BRKR 6.3B
- IPO Year
- PCVX 2020
- BRKR 2000
- Fundamental
- Price
- PCVX $34.50
- BRKR $42.00
- Analyst Decision
- PCVX Strong Buy
- BRKR Buy
- Analyst Count
- PCVX 10
- BRKR 12
- Target Price
- PCVX $136.50
- BRKR $54.50
- AVG Volume (30 Days)
- PCVX 1.5M
- BRKR 2.4M
- Earning Date
- PCVX 08-05-2025
- BRKR 08-05-2025
- Dividend Yield
- PCVX N/A
- BRKR 0.47%
- EPS Growth
- PCVX N/A
- BRKR N/A
- EPS
- PCVX N/A
- BRKR 0.52
- Revenue
- PCVX N/A
- BRKR $3,446,100,000.00
- Revenue This Year
- PCVX N/A
- BRKR $6.43
- Revenue Next Year
- PCVX N/A
- BRKR $4.21
- P/E Ratio
- PCVX N/A
- BRKR $80.70
- Revenue Growth
- PCVX N/A
- BRKR 14.84
- 52 Week Low
- PCVX $27.66
- BRKR $34.10
- 52 Week High
- PCVX $121.06
- BRKR $72.94
- Technical
- Relative Strength Index (RSI)
- PCVX 53.91
- BRKR 60.72
- Support Level
- PCVX $31.79
- BRKR $41.21
- Resistance Level
- PCVX $34.63
- BRKR $43.66
- Average True Range (ATR)
- PCVX 1.38
- BRKR 1.60
- MACD
- PCVX 0.09
- BRKR 0.20
- Stochastic Oscillator
- PCVX 86.31
- BRKR 80.80
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.